Loading…
Options for anyone who cannot or prefers not to take hormones. CBT, prescription medicines including newer non-hormonal classes, lifestyle measures, and an honest look at supplements.
Effective non-hormonal options exist for menopausal symptoms, and they matter for anyone who cannot take hormone therapy, chooses not to, or needs something alongside it. Cognitive behavioural therapy has good evidence, several prescription medicines help hot flashes, and a newer non-hormonal drug class targets them directly. Supplements are the weakest area and the most heavily marketed.
These are not second best by definition. For some symptoms, particularly sleep and the distress associated with hot flashes, psychological approaches perform very well.
CBT has the strongest evidence of the non-drug approaches, and it is recommended in menopause guidance rather than being an alternative-medicine option.
It does not usually reduce how often flashes occur. What it reliably changes is how much they interfere: the anticipatory anxiety, the catastrophic interpretation in social situations, and the sleep disruption that follows. For insomnia specifically, cognitive behavioural therapy for insomnia has strong evidence and is generally preferred over long term sleeping tablets. Ask what is available locally, including digital and group programmes.
Clinical hypnosis is frequently left out of menopause discussions, but The Menopause Society’s 2023 nonhormone therapy position statement places it alongside cognitive behavioural therapy in its highest evidence category for vasomotor symptoms. It involves guided focused attention and suggestion, usually over a small number of sessions with a trained practitioner, and it is worth asking about where hormone therapy is unsuitable.
That same statement groups the recommended nonhormone options by strength of evidence: cognitive behavioural therapy, clinical hypnosis, certain SSRIs and SNRIs, gabapentin and fezolinetant carry its strongest rating, with oxybutynin next, followed by weight loss and stellate ganglion block.
| Class | Mainly used for | Points to discuss |
|---|---|---|
| Certain SSRIs and SNRIs | Hot flashes and night sweats | Used at lower doses than for depression. Some interact with tamoxifen, which matters after breast cancer |
| Gabapentin | Hot flashes, particularly at night | Drowsiness is common, so timing matters |
| Clonidine | Hot flashes | Older option, modest effect, blood pressure effects |
| Oxybutynin | Hot flashes | Anticholinergic effects; caution in older adults |
| Neurokinin receptor antagonists | Moderate to severe hot flashes | Newer non-hormonal class targeting the brain pathway involved. Availability and monitoring requirements vary by country |
Availability, licensing and whether a given medicine is used on or off label differ substantially between countries, so what applies in one health system may not apply in yours. Some of these require monitoring, including liver function tests for certain newer agents.
These are frequently offered as a substitute for treatment, which is unfair, but several have genuine value:
This is where evidence is weakest and marketing strongest. Some general points worth carrying into any purchase decision:
Evidence for isoflavones and red clover is mixed and generally weak. Evening primrose oil has not performed well for hot flashes in trials. Always tell your clinician and pharmacist what you are taking, because interactions are the main practical risk. Our reviews section covers how to judge product claims.
Being direct here is more useful than being diplomatic. Claims to balance hormones, detoxify, or reset metabolism are not meaningful clinical concepts. Saliva hormone testing is not a validated basis for treatment decisions. Compounded bioidentical hormone regimens are not recommended by major menopause societies. Products promising to cure menopause misrepresent what menopause is, since it is a normal life stage rather than a disease to be cured.
A practical order of questions with a clinician:
It depends on the symptom. For hot flashes, certain prescription medicines and the newer non-hormonal class have evidence. For sleep and the distress around symptoms, cognitive behavioural therapy performs well. A combination is common.
Some do, at lower doses than used for depression, and they are prescribed for the flashes themselves rather than for mood. Some interact with tamoxifen, so mention any breast cancer treatment.
Evidence of benefit is mixed and it has been associated with rare liver injury. Discuss it with a clinician or pharmacist first, particularly if you take other medicines or have liver problems.
Because the placebo response in hot flash trials is unusually large, so a substantial proportion of people improve on anything. Testimonials cannot distinguish a real effect from that, which is what controlled trials are for.
This needs an individual answer from your oncology team rather than a general rule. Do not start them on the basis of general information.
Probably not by itself, and the evidence for reducing frequency is weaker than commonly claimed. It remains worth doing for sleep, mood, bone, muscle and cardiovascular health.
No. It does not dispute that symptoms are physical. It targets the anticipatory anxiety, interpretation and sleep disruption that determine how disabling they are, and it has a solid evidence base in menopause specifically.
Often yes. CBT, sleep interventions and lifestyle measures combine with hormone therapy. Combining prescription medicines requires a clinician’s input on interactions.
Non-hormonal treatment is a genuine option rather than a consolation prize. Cognitive behavioural therapy has good evidence, particularly for sleep and for the distress around hot flashes, and several prescription medicines including a newer non-hormonal class help vasomotor symptoms. Lifestyle measures are worth doing for wider health even where their effect on flashes is modest. Supplements are the weakest evidence and the loudest marketing, and their main practical risk is interaction with medicines you already take, so tell your clinician what you are using.
Sources verified 10 September 2026. Clinical guidance is updated periodically, and availability of specific treatments differs by country, so check current national guidance. This article is general information and does not replace individual medical advice. It has not been reviewed by a named clinician; where that changes, the reviewer will be named here.
9 printable pages including a symptom checklist, a 30-day symptom tracker, an appointment checklist and questions to ask — delivered to your inbox.